436 related articles for article (PubMed ID: 7547639)
1. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
[TBL] [Abstract][Full Text] [Related]
2. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.
Henske EP; Scheithauer BW; Short MP; Wollmann R; Nahmias J; Hornigold N; van Slegtenhorst M; Welsh CT; Kwiatkowski DJ
Am J Hum Genet; 1996 Aug; 59(2):400-6. PubMed ID: 8755927
[TBL] [Abstract][Full Text] [Related]
4. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
[TBL] [Abstract][Full Text] [Related]
5. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor.
Green AJ; Johnson PH; Yates JR
Hum Mol Genet; 1994 Oct; 3(10):1833-4. PubMed ID: 7849709
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
Yu J; Astrinidis A; Henske EP
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in tuberous sclerosis hamartomas.
Sepp T; Yates JR; Green AJ
J Med Genet; 1996 Nov; 33(11):962-4. PubMed ID: 8950679
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.
Green AJ; Smith M; Yates JR
Nat Genet; 1994 Feb; 6(2):193-6. PubMed ID: 8162074
[TBL] [Abstract][Full Text] [Related]
9. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
[TBL] [Abstract][Full Text] [Related]
10. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures.
Karbowniczek M; Yu J; Henske EP
Am J Pathol; 2003 Feb; 162(2):491-500. PubMed ID: 12547707
[TBL] [Abstract][Full Text] [Related]
11. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
12. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.
Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN
Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941
[TBL] [Abstract][Full Text] [Related]
13. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
[TBL] [Abstract][Full Text] [Related]
14. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
16. Renal angiomyolipoma (AML) harboring a missense mutation of
Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
[TBL] [Abstract][Full Text] [Related]
17. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
[TBL] [Abstract][Full Text] [Related]
19. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex.
Yang HM; Choi HJ; Hong DP; Joo SY; Lee NE; Song JY; Choi YL; Lee J; Choi D; Kim B; Park HJ; Park JB; Kim SJ
Exp Mol Pathol; 2014 Dec; 97(3):440-4. PubMed ID: 25281918
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]